Table 2.
Medical profiles of patients
| n | % | |
|---|---|---|
| Age (years) | ||
| <40 | 39 | 6.5 |
| 40–59 | 267 | 44.5 |
| ≥60 | 294 | 49.0 |
| BMI | ||
| <18 kg/m2 | 50 | 8.3 |
| 18–25 kg/m2 | 353 | 58.8 |
| 26–30 kg/m2 | 132 | 22.0 |
| >30 kg/m2 | 65 | 10.8 |
| Abdominal circumference (cm) | ||
| <95 | 444 | 74.0 |
| 95–100 | 77 | 12.8 |
| >100 | 79 | 13.2 |
| Monthly income (ERN) | ||
| <500 | 220 | 36.7 |
| 500–1,000 | 104 | 17.3 |
| 1,001–2,000 | 190 | 31.7 |
| >2,000 | 86 | 14.3 |
| Distance from home to work | ||
| <1 km | 302 | 50.3 |
| 1–5 km | 270 | 45.0 |
| >5 km | 28 | 4.7 |
| Transport to work | ||
| Bicycle | 70 | 11.7 |
| Car | 89 | 14.8 |
| On foot | 189 | 31.5 |
| No | 252 | 41.0 |
| Other chronic illness | ||
| Yes | 67 | 11.2 |
| No | 533 | 88.8 |
| Type of diabetes mellitus | ||
| I | 71 | 17.6 |
| II | 334 | 82.4 |
| Duration of diabetes mellitus | ||
| <1 year | 20 | 5.0 |
| 1–5 years | 187 | 46.3 |
| 6–10 years | 102 | 25.2 |
| ≥11 years | 95 | 23.5 |
| Type of DM treatment | ||
| Glibenclamide | 116 | 28.7 |
| Metformin and glibenclamide | 171 | 42.3 |
| Metformin | 30 | 7.4 |
| Insulin | 87 | 21.5 |
| Duration of hypertension | ||
| <1 year | 4 | 1.2 |
| 1–5 years | 189 | 58.5 |
| 6–10 years | 94 | 29.1 |
| ≥11 years | 36 | 11.1 |
| Mean FBS | ||
| 75–120 mg/dL | 92 | 22.8 |
| 121–150 mg/dL | 144 | 35.6 |
| 151–200 mg/dL | 94 | 23.3 |
| >200 | 74 | 18.3 |
| Mean blood pressure | ||
| <130/80 mmHg | 467 | 77.8 |
| >130/80 mmHg | 133 | 22.2 |
| Cardiovascular risk prediction | ||
| <10% | 561 | 93.5 |
| 10%–20% | 32 | 5.3 |
| 20%–30% | 3 | 0.5 |
| 30%–40% | 4 | 0.7 |
| Total | 600 | 100 |